Trial Profile
A safety and efficacy study of TC-1734-112 [ispronicline] in subjects with age associated memory impairment (AAMI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2011
Price :
$35
*
At a glance
- Drugs Ispronicline (Primary)
- Indications Memory disorders
- Focus Adverse reactions; Therapeutic Use
- 18 Jul 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 22 Oct 2005 New trial record.